Advisor Resource Council Amarin Corp Plcuk Transaction History

Advisor Resource Council

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$1.13 - $3.69 $27,906 - $91,128	24,696 New	24,696 $37,000
Q1 2022 Apr 20, 2022	SELL	$2.85 - $3.73 $114,709 - $150,128	-40,249 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.24 - $5.18 $130,406 - $208,489	40,249 New	40,249 $135,000
Q3 2021 Nov 16, 2021	SELL	$3.94 - $5.84 $123,325 - $182,797	-31,301 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$4.26 - $6.5 $132,758 - $202,566	31,164 Added 22747.45%	31,301 $137,000
Q2 2021 Aug 13, 2021	BUY	$4.26 - $6.5 $583 - $890	137 New	137 $0

182

71.1M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.